Author:
Vriesendorp P. A.,Wilschut J. M.,Diletti R.,Daemen J.,Kardys I.,Zijlstra F.,Van Mieghem N. M.,Bennett J.,Esposito G.,Sabate M.,den Dekker W. K.
Abstract
AbstractAlthough there is robust evidence that revascularisation of non-culprit vessels should be pursued in patients presenting with an acute coronary syndrome (ACS) and multivessel coronary artery disease (MVD), the optimal timing of complete revascularisation remains disputed. In this systematic review and meta-analysis our results suggest that outcomes are comparable for immediate and staged complete revascularisation in patients with ACS and MVD. However, evidence from randomised controlled trials remains scarce and cautious interpretation of these results is recommended. More non-biased evidence is necessary to aid future decision making on the optimal timing of complete revascularisation.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine